Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
Stroke 33:2664-2669, Scott,P.A.,et al, 2002
Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy
Stroke 33;2722-2727, Hart,R.G.,et al, 2002
Blepharospasm
Neurol 59:1306-1312, Hallett,M., 2002
Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
JAMA 288:2441-2448, van Walraven,C.,et al, 2002
Stimulation of the Subthalamic Nucleus Increases Heart Rate in Patients with Parkinson Disease
Neurol 59:1657-1658, Kaufmann,H.,et al, 2002
Infective Endocarditis Resulting from CardioSEAL Closure of a Patent Foramen Ovale
Catheter Cardiovasc Interv 55:217-220, Goldstein,J.A.,et al, 2002
Hypertrophic Cardiomyopathy A Systematic Review
JAMA 287:1308-1320, Maron, B.J., 2002
Fat embolism syndrome and elective knee arthroplasty
Can J Anesth 49:19-23, Jenkins, K.,et al, 2002
Clinical Profile of Stroke in 900 Patients with Hypertrophic Cardiomyopathy
J Am Coll Cardiol 39:301-307, Maron,B.J.,et al, 2002
Cardiac Papillary Fibroelastoma as a Cause of Recurrent Ischemic Strokes: The Diagnostic Value of Serial Transesophageal Echocardiography
Cerebrovasc Dis 14:256-259, Baba, Y.,et al, 2002
The Differential Diagnosis of Multiple Sclerosis
JNNP 71(suppl II):ii9-ii15, Scolding, N., 2001
Is Patent Foramen Ovale a Family Trait?
Stroke 32:1563-1566, Arquizan,C.,et al, 2001
MR Diagnosis of Myxomatous Aneurysms: Report of Two Cases
AJNR 22:1349-1352, Nucifora,P.G.P .&Dillon,W.P., 2001
Asystole Induced by Edrophonium Following Beta Blockade
Neurol 57:739, Okun,M.S.,et al, 2001
Primary Prevention of Ischemic Stroke
Stroke 32:280-299, Goldstein,L.B.,et al, 2001
Ear Oximetry: A Noninvasive Method for Detection of Patent Foramen Ovale
Stroke 32:448-453, Karttunen,V.,et al, 2001
Systematic Review of Long Term Anticoagulation or Antiplatelet Treatment in Patients with Non-rheumatic Atrial Fibrillation
BMJ 322:321-326, Taylor,F.C.,et al, 2001
Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial
Stroke 32:2333-2337, Saxena,R.,et al, 2001
Should Stroke Subtype Influence Anticoagulation Decisions to Prevent Recurrence in Stroke Patients with Atrial Fibrillation?
Stroke 32:2828-2832, Evans,A.,et al, 2001
Recurrent Cerebrovascular Events Associated With Patent Foramen Ovale, Atrial Septal Aneurysm, or Both
NEJM 345:1740-1746, Mas,J.,et al, 2001
Thrombolytic Therapy in Acute Ischemic Stroke Patients With Cardiac Thrombus
Neurol 57:2122-2125, Derex,L.,et al, 2001
Late Cardiopulmonary Complication of Ventriculo-atrial Shunt
Lancet 358:1608,1569, Milton,C.A.,et al, 2001
Warfarin Therapy for an Octogenarian who has Atrial Fibrillation
Ann Int Med 134:465-474, Gage,B.F.,et al, 2001
Atrial Fibrillation
NEJM 344:1067-1078, Falk,R.H., 2001
Clinical Presentation of Left Atrial Cardiac Myxoma
Medicine 80:159-172, Pinede,L.,et al, 2001
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
Desmin Myopathy, a Skeletal Myopathy with Cardiomyopathy Caused by Mutations in the Desmin Gene
NEJM 342:770-780, Dalakas,M.C.,et al, 2000
Decision Analysis and Guidelines for Anticoagulant Therapy to Prevent Stroke in Patients with Atrial Fibrillation
Lancet 355:956-962, Thomson,R.,et al, 2000
Cardiac Dysfunction in Neuromuscular Diseases
The Neurologist 6:67-82, Pourmand,R., 2000
Anticoagulation for Chronic Atrial Fibrillation
JAMA 283:2901-2903, Stern,S.,et al, 2000
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
Atrial Fibrilation and the Risk of Cerebral White Matter Lesions
Neurol 54:1795-1801, de Leeuw,F.E.,et al, 2000
Low Molecular-Weight Heparin Versus Aspirin in Patients With Acute Ischaemic Stroke and Atrial Fibrillation: A Double-Blind Randomised Study
Lancet 355:1205-1210, Berge,E.,et al, 2000
Optimal Intensity of Warfarin Therapy for Secondary Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation
Stroke 31:817-821, Yamaguchi,T., 2000
Misdiagnosis of Epilepsy: Many Seizure-Like Attacks Have a Cardiovascular Cause
J Am Coll Cardiol 36:181-184, Zaidi,A. et al, 2000
Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000
Atrial Fibrillation Associated with Sumatriptan
BMJ 321:275, Morgan,D.R. et al, 2000
Coexisting Causes of Ischemic Stroke
Arch Neurol 57:1139-1144,1113, Moncayo,J. et al, 2000
Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000
Effect on Migraine of Closure of Cardiac Right-to-Left Shunts to Prevent Reucrrence of Decompression Illness or Stroke or for Haemodynamic Reasons
Lancet 356:1648-1651, Wilmshurst,P.T.,et al, 2000
The Association Between the Diameter of a Patent Foramen Ovale and the Risk of Embolic Cerebrovascular Events
Am J Med 109:456-462,506, Schuchlenz,H.W.,et al, 2000
Interatrial Septal Abnormalities and Stroke
Neurol 55:1172-1179, Overell,J.R.,et al, 2000
Complications During Apnea Testing in the Determination of Brain Death: Predisposing Factors
Neurol 55:1045-1048, Goudreau,J.L.,et al, 2000
Pulmonary Arteriovenous Malformations
Neurol 55:959-964, Moussouttas,M.,et al, 2000
Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications
Stroke 31:2407-2413, De Castro,S.,et al, 2000
Cardiac Arrhythmias and Stroke
Stroke 31:2925-2929, Engstrom,G.,et al, 2000
Syncope
NEJM 343:1856-1862, Kapoor,W.N., 2000
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000
Arteriovenous Bubbles Following Cold Water Sport Dives: Relation to Right-to-left Shunting
Neurol 55:1741-1743, Gerriets,T.,et al, 2000